Valeant reports better-than-expected profit, raises forecast
(Reuters) - Canada's Valeant Pharmaceuticals International Inc , embroiled in a bitter fight to take over Botox maker Allergan Inc , posted a better-than-expected quarterly profit, driven by demand for its skin, neuro and eye drugs. (Source: Reuters: Health)
Source: Reuters: Health - October 20, 2014 Category: Consumer Health News Tags: healthNews Source Type: news

Eyes watering all the time? You may need a Botox jab 
Watering eyes are normally due to a problem with the drainage of tears, which help lubricate the eye, protecting it from damage and keeping it healthy. (Source: the Mail online | Health)
Source: the Mail online | Health - October 14, 2014 Category: Consumer Health News Source Type: news

Giving botox a safer facelift: Structures of botulinum neurotoxins studied
New insights into botulinum neurotoxins and their interactions with cells are moving scientists ever closer to safer forms of Botox and a better understanding of the dangerous disease known as botulism. By comparing all known structures of botulinum neurotoxins, researchers suggest new ways to improve the safety and efficacy of Botox injections. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - October 1, 2014 Category: Science Source Type: news

Ackman threatens to sue Allergan again over potential Salix deal
Billionaire William Ackman's Pershing Square Capital Management threatens to sue Allergan if it goes ahead with a deal to buy drugmaker Salix Pharmaceuticals. (Reuters) - Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd. Pershing Square Capital Management, Valeant Pharmaceuticals, Allergan Inc.Legal News, News Well, Mergers & Acquisitions, Wall Street Beatread more (Source: Mass Device)
Source: Mass Device - September 24, 2014 Category: Medical Equipment Authors: MassDevice Source Type: news

Ackman Threatens to Sue Allergan
Activist investor William Ackman threatend to sue Allergan if the Botox maker makes a deal to acquire Salix Pharmaceuticals. (Source: WSJ.com: Health)
Source: WSJ.com: Health - September 24, 2014 Category: Pharmaceuticals Tags: PAID Source Type: news

Eyebrow droop, double vision and bruising: 5 negative side effects of Botox
BEFORE you opt for the muscle-paralysing injections you should know all the facts - so we've asked an expert in the field to discuss the possible unwanted side effects and how to avoid them (Source: Daily Express - Health)
Source: Daily Express - Health - September 18, 2014 Category: Consumer Health News Source Type: news

Botox 'stunts emotional growth'
Experts warn that treating young people with Botox injections could restrict their emotional and social development. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - September 13, 2014 Category: Consumer Health News Source Type: news

HypeWatch: Botox for Gastric Cancer? Think Again
(MedPage Today) -- Overselling is becoming epidemic and endemic. Promoting unproven therapies, as a recent story about a gastric cancer study did, is not going to get us where we need to be, says J. Leonard Lichtenfeld of the American Cancer Society. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - September 3, 2014 Category: Primary Care Source Type: news

From Botox to 'grow your own' cartilage - how to ease your bad knees
A report in the Canadian Medical Journal found that a common type of knee surgery called arthroscopy does little to help osteoarthritis. (Source: the Mail online | Health)
Source: the Mail online | Health - September 2, 2014 Category: Consumer Health News Source Type: news

Is there ANYTHING that Botox can't treat?
Botox has been officially approved for 12 conditions, and just this month, it was revealed the toxin may combat stomach cancer and trials are under way. (Source: the Mail online | Health)
Source: the Mail online | Health - August 31, 2014 Category: Consumer Health News Source Type: news

Ear-tox, Brazilian butt sculpting and KNEE peels: The bizarre - and possibly painful - future of cosmetic surgery
This year has been all about the bacial (that's a bum facial), ear-tox (yes, Botox for your ears) and freckle removal. But it's about to get a lot crazier. (Source: the Mail online | Health)
Source: the Mail online | Health - August 28, 2014 Category: Consumer Health News Source Type: news

7st woman misdiagnosed as anorexic is given Botox injections to 'freeze' her stomach tissue, allowing her to keep food down
Jade Nock, 25, from Suffolk was told she was anorexic after her weight plummeted to seven stone because she was unable to keep any solid food down. (Source: the Mail online | Health)
Source: the Mail online | Health - August 28, 2014 Category: Consumer Health News Source Type: news

Allergan accedes to special meeting, asks court to block Valeant's vote
Botox-maker Allergan acquiesces to Valeant Pharmaceuticals' demands for a special shareholder meeting, but takes to court to prevent Valeant and its compatriots from voting their shares. Pershing Capital Management, Valeant Pharmaceuticals, Allergan Inc.Legal News, News Well, Cosmetic/Aesthetic, Mergers & Acquisitionsread more (Source: Mass Device)
Source: Mass Device - August 27, 2014 Category: Medical Equipment Authors: Arezu Sarvestani Source Type: news

Valeant Pushes Ahead in Allergan Fight
Amid hostile takeover bid, it asks a judge to speed vote that could oust a majority of the Botox maker's board. (Source: WSJ.com: Health)
Source: WSJ.com: Health - August 25, 2014 Category: Pharmaceuticals Tags: PAID Source Type: news

Live Well: Botox could help halt stomach cancer and city children more likely to suffer food allergies
Live Well: Every week, The Telegraph rounds up the best of this week's scientific studies and developments which will help you live a happier, healthier, longer life (Source: Telegraph Health)
Source: Telegraph Health - August 22, 2014 Category: Consumer Health News Tags: healthy living healthy lifestyle botox health news stomach cancer live well Source Type: news

Botox Prevents Development, Spread of Gastric CancerBotox Prevents Development, Spread of Gastric Cancer
Denervation of the stomach, through surgery or botulinum toxin (Botox) injections, blocks the signalling pathways that promote gastric cancer and stops tumors from developing and spreading. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 21, 2014 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Botox may be useful in treating stomach cancers
ConclusionThese laboratory experiments show that nerves have a role in the development and advancement of stomach cancer. The early experiments in mice found that stopping the nervous supply by either cutting the vagus nerve or injecting it with Botox improved survival rates and reduced cancer growth.The Botox injections were not performed on any humans in this study. However, an early-phase clinical trial in humans with inoperable stomach cancer began in Norway in January 2013, with the results expected in 2016. This will determine the safety of such a procedure and work out the number of people who would need to be treat...
Source: NHS News Feed - August 21, 2014 Category: Consumer Health News Tags: Cancer Source Type: news

Botox Tested on Stomach Cancer in Mice
Title: Botox Tested on Stomach Cancer in MiceCategory: Health NewsCreated: 8/20/2014 4:36:00 PMLast Editorial Review: 8/21/2014 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - August 21, 2014 Category: Cancer & Oncology Source Type: news

Botox may have cancer fighting role
Botox injections - beloved by those seeking a wrinkle-free complexion - may help fight cancer, early animal studies suggest. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - August 21, 2014 Category: Consumer Health News Source Type: news

Botox Tested on Stomach Cancer in Mice
Preliminary research suggests the wrinkle treatment Botox might silence critical nerves that support tumors (Source: WebMD Health)
Source: WebMD Health - August 21, 2014 Category: Consumer Health News Source Type: news

Severing nerves may shrink stomach cancers: Botox injections slow growth of stomach tumors in mice
Nerves may play a critical role in stomach cancer growth and that blocking nerve signals using surgery or Botox® (onabotulinumtoxinA) could be an effective treatment for the disease. Stomach cancer is the fourth-leading type of cancer and the second-highest contributor to cancer mortality worldwide, with a 5-year survival rate of less than 25 percent. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - August 20, 2014 Category: Science Source Type: news

Botox could be used as new treatment for stomach cancer, experts say
U.S. researchers found the rejuvenating anti-wrinkle treatment slows tumour growth by blocking nerve signals that stimulate cancer stem cells. (Source: the Mail online | Health)
Source: the Mail online | Health - August 20, 2014 Category: Consumer Health News Source Type: news

Botox Tested on Stomach Cancer in Mice
Preliminary research suggests the wrinkle treatment might silence critical nerves that support tumors (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - August 20, 2014 Category: Cancer & Oncology Authors: webmaster at doctorslounge.com Tags: Dermatology, Oncology, Research, News, Source Type: news

One More Wrinkle in Battle for Botox Firm Allergan
Allergan approached Salix Pharmaceuticals and at least one other company about a potential acquisition, as the Botox maker seeks to fend off a $53 billion hostile takeover from Valeant Pharmaceuticals. (Source: WSJ.com: Health)
Source: WSJ.com: Health - August 20, 2014 Category: Pharmaceuticals Tags: PAID Source Type: news

Severing nerves may shrink stomach cancers: Botox injections slow growth of tumors in mice
(Columbia University Medical Center) Research from Columbia University Medical Center shows that nerves may play a critical role in stomach cancer growth and that blocking nerve signals using surgery or Botox could be an effective treatment for the disease. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 20, 2014 Category: Cancer & Oncology Source Type: news

Treating gastric cancer -- with Botox
(Norwegian University of Science and Technology) In an article published in the Aug. 20 edition of Science Translational Medicine, a team of international researchers reports that gastric cancer growth could be suppressed by eliminating the signals sent by nerves that are linked to cancer stem cells. The use of Botox to cut the connection between the nerves and the stem cells made the treatment cheap, safe and efficient. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 20, 2014 Category: Cancer & Oncology Source Type: news

Tummy tucks, botox and silicone testicles: the weird and wonderful world of pet plastic surgery
As the craze for wrinkly-faced dogs leads to an 80 per cent rise in pet facelifts, why else do our dogs go under the knife? (Source: Telegraph Health)
Source: Telegraph Health - August 19, 2014 Category: Consumer Health News Tags: tummy tucks facelift pugs plastic surgery botox bulldog pets celebrities Source Type: news

Britain's vainest man demands botox for life from NHS just months after free £5k nose job
Sam Barton, 22, from Sutton Coldfield, claims he needs new cosmetic treatments to combat symptoms of anxiety caused his ‘new-found fame’. (Source: the Mail online | Health)
Source: the Mail online | Health - August 16, 2014 Category: Consumer Health News Source Type: news

Botox could halt stomach cancer
Anti-wrinkle treatment could be used to suppress stomach cancer after a successful trial using mice (Source: Telegraph Health)
Source: Telegraph Health - August 12, 2014 Category: Consumer Health News Source Type: news

Well: Bothered by a ‘Gummy Smile’
People bothered by a smile that shows too much of the gum line have a new option: Botox. (Source: NYT)
Source: NYT - July 31, 2014 Category: American Health Authors: By ABBY ELLIN Tags: Plastic Surgery Botox (Drug) Body Gums (Mouth) medicine and health Teeth and Dentistry Featured Source Type: news

Well: Bothered by a ‘Gummy Smile’
People bothered by a smile that shows too much of the gum line have a new option: Botox. (Source: NYT Health)
Source: NYT Health - July 31, 2014 Category: Consumer Health News Authors: By ABBY ELLIN Tags: Plastic Surgery Botox (Drug) Body Gums (Mouth) medicine and health Teeth and Dentistry Featured Source Type: news

Well: Bothered by a ‘Gummy Smile’
People bothered by a smile that shows too much of the gum line have a new option: Botox. (Source: NYT)
Source: NYT - July 31, 2014 Category: Nutrition Authors: By ABBY ELLIN Tags: Plastic Surgery Botox (Drug) Body Gums (Mouth) medicine and health Teeth and Dentistry Featured Source Type: news

Allergan gets EU recommendation on new use of eye drug
(Reuters) - Allergan Inc, known best for its Botox wrinkle treatment, said on Friday that European Union regulators had recommended use of its eye drug Ozurdex be extended to treat patients with diabetic macular edema. (Source: Reuters: Health)
Source: Reuters: Health - July 25, 2014 Category: Consumer Health News Tags: healthNews Source Type: news

Botox Helps Overactive Bladder Beyond 2 YearsBotox Helps Overactive Bladder Beyond 2 Years
In the first long-term study of Botox for overactive bladder, efficacy and safety persisted for a median of 2.4 years with no additional safety issues, report researchers. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 24, 2014 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

Allergan to Cut 13% of Workforce
Allergan outlined plans to cut 13% of its workforce, part of a restructuring plan intended to save $475 million as the Botox maker looks to stave off an unsolicited $53 billion takeover bid from Valeant. (Source: WSJ.com: Health)
Source: WSJ.com: Health - July 22, 2014 Category: Pharmaceuticals Tags: PAID Source Type: news

Allergan cuts 1,500 jobs, faces SEC complaint
Botox-maker Allergan announces restructuring measures that will cut 13% of its global workforce as the company sinks deeper into a months-long battle against activist investors and attempts at a takeover. Updated July 21, 2014, at 12:40 p.m. EST with additional information on Allergan's earnings. Pershing Capital Management, Valeant Pharmaceuticals, Allergan Inc.News Well, Cosmetic/Aesthetic, Layoffs, Mergers & Acquisitions, Personnel Moves, Pharmaceuticals, Wall Street Beatread more (Source: Mass Device)
Source: Mass Device - July 21, 2014 Category: Medical Equipment Authors: Arezu Sarvestani Source Type: news

Big Allergan Investor Sells Most of Stake
Allergan shareholder Capital Research and Management has sold nearly all of its holdings in the Botox maker's stock amid Valeant's takeover attempt. (Source: WSJ.com: Health)
Source: WSJ.com: Health - July 21, 2014 Category: Pharmaceuticals Tags: PAID Source Type: news

'Botox can ease shingles agony': Anti-wrinkle drug found to be effective treatment of nerve pain
Botox was found to be more effective than the anaesthetic lidocaine when extreme nerve pain continues after a shingles rash has healed. (Source: the Mail online | Health)
Source: the Mail online | Health - July 6, 2014 Category: Consumer Health News Source Type: news

Report: Another activist investor pressures Allergan to sell
Another hedge fund buys a massive stake in Botox-maker Allergan, throwing its support behind Valeant Pharmaceuticals' unrequited acquisition bid, according to a report. Another player entered the arena in the running saga over Allergan (NYSE:AGN) as hedge fund Paulson & Co bought up a huge chunk of the Botox-maker's shares, according to Reuters. Paulson & Co. Inc., Pershing Capital Management, Valeant Pharmaceuticals, Allergan Inc.Legal News, News Well, Cosmetic/Aesthetic, Mergers & Acquisitions, Pharmaceuticals, Wall Street Beatread more (Source: Mass Device)
Source: Mass Device - June 27, 2014 Category: Medical Equipment Authors: Arezu Sarvestani Source Type: news

Allergan Turns Down Valeant's Merger Offer
After reviewing Valeant’s takeover proposal last week, Allergan today announced it has deemed the offer “grossly inadequate,” leading the botox maker’s board turned down the bid in a unanimous vote. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - June 25, 2014 Category: Pharmaceuticals Source Type: news

More Evidence Botox Works for Depression
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 23, 2014 Category: Journals (General) Source Type: news

More Evidence Botox Works for Depression
Title: More Evidence Botox Works for DepressionCategory: Health NewsCreated: 6/20/2014 11:00:00 AMLast Editorial Review: 6/20/2014 12:00:00 AM (Source: MedicineNet Depression General)
Source: MedicineNet Depression General - June 20, 2014 Category: Psychiatry Source Type: news

Drug-maker Valeant begins exchange offer for Allergan
(Reuters) - Valeant Pharmaceuticals Inc said on Wednesday it began an exchange offer for Botox maker Allergan Inc, taking its hostile $50.8 billion bid directly to shareholders. (Source: Reuters: Health)
Source: Reuters: Health - June 19, 2014 Category: Consumer Health News Tags: healthNews Source Type: news

More Evidence Botox Works for Depression
A single injection of Botox, which is typically used to improve the appearance of facial wrinkles, may be an effective treatment for depression. (Source: WebMD Health)
Source: WebMD Health - June 19, 2014 Category: Consumer Health News Source Type: news

Valeant goes hostile in bid for Allergan
Valeant Pharmaceuticals makes its promised hostile play in a $53 billion attempt to take over Botox-maker Allergan. Valeant Pharmaceuticals is preparing to officially launch its long-promised hostile takeover bid for Allergan (NYSE:AGN), aiming to solicit support from Allergan shareholders to host a special meeting outside of the company's control. Pershing Capital Management, Valeant Pharmaceuticals, Allergan Inc.News Well, Cosmetic/Aesthetic, Mergers & Acquisitions, Pharmaceuticals, Wall Street Beatread more (Source: Mass Device)
Source: Mass Device - June 18, 2014 Category: Medical Equipment Authors: Arezu Sarvestani Source Type: news

Allergan, Defending Its Fort Botox
The feisty chief of Allergan, Botox’s maker, says a takeover would imperil the company’s drug-discovery mission. (Source: NYT Health)
Source: NYT Health - June 14, 2014 Category: Consumer Health News Authors: By NATASHA SINGER Tags: Valeant Pharmaceuticals International Inc VRX NYSE Botox (Drug) Inventions and Patents Novartis AG NVS NYSE Mergers, Acquisitions and Divestitures Allergan Inc AGN NYSE Pyott, David E I Source Type: news

More Evidence Botox Works for DepressionMore Evidence Botox Works for Depression
A growing number of studies suggest botulinum injections, which are typically used to improve the appearance of wrinkles, may be an effective treatment for depression. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 13, 2014 Category: Consumer Health News Tags: Psychiatry News Source Type: news

Allergan proxy war gets ugly as Valeant aims to unseat the board
Activist investor Bill Ackman teams up with Valeant Pharmaceuticals to push out members of Allergan's board in an increasingly hostile attempt to acquire the Botox-maker. After sweetening the pot last week, activist investor Valeant Pharmaceuticals is taking a more aggressive approach in its unsolicited (and unrequited) attempt to buy Botox-maker Allergan (NYSE:AGN). Pershing Capital Management, Valeant Pharmaceuticals, Allergan Inc.News Well, Cosmetic/Aesthetic, Mergers & Acquisitions, Pharmaceuticals, Wall Street Beatread more (Source: Mass Device)
Source: Mass Device - June 2, 2014 Category: Medical Equipment Authors: Arezu Sarvestani Source Type: news

Allergan Bid Nears $53 Billion
Valeant Pharmaceuticals boosted its takeover bid for Botox-maker Allergan for the second time this week, offering about $52.7 billion in cash and stock. (Source: WSJ.com: Health)
Source: WSJ.com: Health - May 31, 2014 Category: Pharmaceuticals Tags: PAID Source Type: news

Allergan Bid Approaches $53 Billion
Valeant Pharmaceuticals boosted its takeover bid for Botox-maker Allergan for the second time this week, offering about $52.7 billion in cash and stock, partly thanks to its partner in the bid, William Ackman, offering to take a price cut on his own Allergan shares. (Source: WSJ.com: Health)
Source: WSJ.com: Health - May 31, 2014 Category: Pharmaceuticals Tags: PAID Source Type: news